Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06094205 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia (BG-Speech-02)

Study acronym: BG-Speech-02
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. 2 versions Re-verified since Nov 27, 2024, no change to tracked fieldsv6-v7
  2. Start date changed from estimate of Oct 2024 to Oct 16, 2023v5
  3. Eligibility criteria shortened, about 26 wordsv4
  4. Site details revisedv3
  5. Re-verified, no change to tracked fieldsv2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Leigh R. Hochberg, MD, PhD.
5 trials monitored
See all monitored trials
Stroke
3,531 trials monitored
See 153 trials at risk
ALS
398 trials monitored
See 21 trials at risk
The goal of this study is to improve our understanding of speech production, and to translate this into medical devices called intracortical brain-computer interfaces (iBCIs) that will enable people who have lost the ability to speak fluently to communicate via a computer just by trying to speak.
Trial Details
NCT Number NCT06094205
Lead Sponsor Leigh R. Hochberg, MD, PhD.
Collaborators: National Institute on Deafness and Other Communication Disorders (NIDCD)
Conditions
(from sponsor)		 Anarthria, Dysarthria, Tetraplegia, Spinal Cord Injuries, Amyotrophic Lateral Sclerosis, Brain Stem Infarctions, Locked-in Syndrome, Muscular Dystrophies
Related terms Amyotrophic Lateral Sclerosis, Brain Stem Infarctions, Dysarthria, Locked-In Syndrome, Muscular Dystrophies, Quadriplegia, Spinal Cord Injuries
Enrollment 2 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov